Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine - PubMed (original) (raw)

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine

Fayaz Malik et al. Apoptosis. 2007 Nov.

Abstract

Induction of apoptosis in cancer cells has become the major focus of anti-cancer therapeutics development. WithaferinA, a major chemical constituent of Withania somnifera, reportedly shows cytotoxicity in a variety of tumor cell lines while its molecular mechanisms of action are not fully understood. We observed that withaferinA primarily induces oxidative stress in human leukemia HL-60 cells and in several other cancer cell lines. The withanolide induced early ROS generation and mitochondrial membrane potential (Deltapsi(mt)) loss, which preceded release of cytochrome c, translocation of Bax to mitochondria and apoptosis inducing factor to cell nuclei. These events paralleled activation of caspases -9, -3 and PARP cleavage. WA also activated extrinsic pathway significantly as evidenced by time dependent increase in caspase-8 activity vis-à-vis TNFR-1 over expression. WA mediated decreased expression of Bid may be an important event for cross talk between intrinsic and extrinsic signaling. Furthermore, withaferinA inhibited DNA binding of NF-kappaB and caused nuclear cleavage of p65/Rel by activated caspase-3. N-acetyl-cysteine rescued all these events suggesting thereby a pro-oxidant effect of withaferinA. The results of our studies demonstrate that withaferinA induced early ROS generation and mitochondrial dysfunction in cancer cells trigger events responsible for mitochondrial -dependent and -independent apoptosis pathways.

PubMed Disclaimer

Cited by

A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4.
Rah B, Amin H, Yousuf K, Khan S, Jamwal G, Mukherjee D, Goswami A. Rah B, et al. PLoS One. 2012;7(9):e44039. doi: 10.1371/journal.pone.0044039. Epub 2012 Sep 4. PLoS One. 2012. PMID: 22962598 Free PMC article.
Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer.
Hsu JH, Chang PM, Cheng TS, Kuo YL, Wu AT, Tran TH, Yang YH, Chen JM, Tsai YC, Chu YS, Huang TH, Huang CF, Lai JM. Hsu JH, et al. Cancers (Basel). 2019 Jul 17;11(7):1003. doi: 10.3390/cancers11071003. Cancers (Basel). 2019. PMID: 31319622 Free PMC article.
Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T, Okla MK, Ahmed M, Akhtar N, Al-Hashimi A, Abdelgawad H, Haq IU. Sultana T, et al. Molecules. 2021 Dec 20;26(24):7696. doi: 10.3390/molecules26247696. Molecules. 2021. PMID: 34946778 Free PMC article. Review.
Withaferin A Inhibits Neutrophil Adhesion, Migration, and Respiratory Burst and Promotes Timely Neutrophil Apoptosis.
Bayless RL, Sheats MK, Jones SL. Bayless RL, et al. Front Vet Sci. 2022 Jun 17;9:900453. doi: 10.3389/fvets.2022.900453. eCollection 2022. Front Vet Sci. 2022. PMID: 35782542 Free PMC article.
Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells.
Stan SD, Zeng Y, Singh SV. Stan SD, et al. Nutr Cancer. 2008;60 Suppl 1(Suppl 1):51-60. doi: 10.1080/01635580802381477. Nutr Cancer. 2008. PMID: 19003581 Free PMC article.

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine - PubMed (original) (raw)